The "key" to vaccine development depends on virus’ binding to human cells
New variants of the SARS-CoV-2 virus most likely will necessitate the development of more vaccine options in the years ahead,
Read more
Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Three emergent SARS-like diseases
Read more
New research proposes innovative antibody-based treatment to prevent SARS-CoV-2 viral entry
A brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy
Read more
Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies
The immune response to infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus
Read more
Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Read more